212 related articles for article (PubMed ID: 24806332)
1. Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway.
Liu T; Zhou W; Zhang F; Shi G; Teng H; Xiao J; Wang Y
Mol Med Rep; 2014 Jul; 10(1):169-74. PubMed ID: 24806332
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
3. IRX2-mediated upregulation of MMP-9 and VEGF in a PI3K/AKT-dependent manner.
Liu T; Zhou W; Cai B; Chu J; Shi G; Teng H; Xu J; Xiao J; Wang Y
Mol Med Rep; 2015 Sep; 12(3):4346-4351. PubMed ID: 26062523
[TBL] [Abstract][Full Text] [Related]
4. EMP1 promotes the malignant progression of osteosarcoma through the IRX2/MMP9 axis.
Wang M; Liu T; Hu X; Yin A; Liu J; Wang X
Panminerva Med; 2020 Sep; 62(3):150-154. PubMed ID: 32716150
[TBL] [Abstract][Full Text] [Related]
5. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
6. miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway.
Liu Z; Liu Z; Zhang Y; Li Y; Liu B; Zhang K
Biochem Biophys Res Commun; 2017 Apr; 486(2):211-217. PubMed ID: 28189676
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH
Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828
[TBL] [Abstract][Full Text] [Related]
8. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
9. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Li YJ; Dong BK; Fan M; Jiang WX
Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma.
Shen A; Zhang Y; Yang H; Xu R; Huang G
J Surg Oncol; 2012 Jun; 105(8):830-4. PubMed ID: 22213004
[TBL] [Abstract][Full Text] [Related]
11. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y
Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486
[TBL] [Abstract][Full Text] [Related]
13. Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKT.
Chen Q; Sun W; Liao Y; Zeng H; Shan L; Yin F; Wang Z; Zhou Z; Hua Y; Cai Z
Mol Med Rep; 2015 Jul; 12(1):219-25. PubMed ID: 25695619
[TBL] [Abstract][Full Text] [Related]
14. Phyllanthus urinaria suppresses human osteosarcoma cell invasion and migration by transcriptionally inhibiting u-PA via ERK and Akt signaling pathways.
Lu KH; Yang HW; Su CW; Lue KH; Yang SF; Hsieh YS
Food Chem Toxicol; 2013 Feb; 52():193-9. PubMed ID: 23201449
[TBL] [Abstract][Full Text] [Related]
15. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
[TBL] [Abstract][Full Text] [Related]
17. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
[TBL] [Abstract][Full Text] [Related]
18. The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor.
Chen KT; Hour MJ; Tsai SC; Chung JG; Kuo SC; Lu CC; Chiu YJ; Chuang YH; Yang JS
Int J Oncol; 2011 Sep; 39(3):611-9. PubMed ID: 21667022
[TBL] [Abstract][Full Text] [Related]
19. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
[TBL] [Abstract][Full Text] [Related]
20. Activin A regulates proliferation, invasion and migration in osteosarcoma cells.
Zhu J; Liu F; Wu Q; Liu X
Mol Med Rep; 2015 Jun; 11(6):4501-7. PubMed ID: 25634369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]